What We're Reading: Page
Industry reads hand-picked by our editors
Aug 15, 2017
-
Bloomberg
What’s harder than making copycat biotech drugs? Selling them
-
The New York Times
Outraged in private, many C.E.O.s fear the wrath of the president
-
The Wall Street Journal
Why early peeks at drug trials are giving investors whiplash
Aug 14, 2017
Aug 11, 2017
Aug 10, 2017
Aug 09, 2017
Aug 08, 2017
Aug 07, 2017
-
The New York Times
Take the generic, patients are told. Until they are not.
-
Bloomberg
Teva's trouble was predicted. Path to recovery not as clear
-
Financial Times
GSK chief says her lack of ‘baggage’ in pharma is an advantage
Previous
